Skip to main content
Caplight Logo









NapiFeryn BioTech

NapiFeryn BioTech

Private
ŁódźHealthcare & Life Scienceshttp://napiferyn.pl/

Last Round

Grant

Sep 11, 2023

Total Funding Raised

$6.93M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NapiFeryn BioTech is a biotechnology company that has developed and patented a technology to extract food-grade proteins from oilseed side-streams.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing, Circular Economy

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

rapeseed proteinplant-based proteinalternative proteinprotein isolatefood techupcyclingcircular economyfood ingredientprotein extractionbiotechnologysustainable foodfood waste reductionnovel foodagritech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NapiFeryn BioTech Comparables

Compare NapiFeryn BioTech with similar companies based on industry and business-model similarity.

NapiFeryn BioTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biodel AG
82%
ChickP Protein
76%
B-hive Innovations
76%

NapiFeryn BioTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 11, 2023
VC RoundJan 30, 2023
GrantAug 12, 2020
GrantJun 3, 2019
GrantJul 1, 2017
Grant
Nov 1, 2016

NapiFeryn BioTech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors increased 415% MoM, from 60 to 309.

  • May 2, 2025

    Monthly visitors increased 391% MoM.

NapiFeryn BioTech Filings

Explore SEC and related filing metadata, where available.

NapiFeryn BioTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NapiFeryn BioTech's valuation, stock price, and market status.

Is NapiFeryn BioTech a public or private company?

NapiFeryn BioTech is a private company.

What is the current stock price of NapiFeryn BioTech?

NapiFeryn BioTech is a private company with no public stock price. Caplight tracks NapiFeryn BioTech's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is NapiFeryn BioTech worth (valuation)?

Valuation information for NapiFeryn BioTech is not publicly available.

Can I buy NapiFeryn BioTech stock?

NapiFeryn BioTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NapiFeryn BioTech's last funding round?

NapiFeryn BioTech's most recent funding round was Grant on September 11, 2023.

Who are the main investors in NapiFeryn BioTech?

Key investors in NapiFeryn BioTech include ICOS Capital.

Will NapiFeryn BioTech IPO soon?

No public IPO plans have been announced for NapiFeryn BioTech.

How can I track NapiFeryn BioTech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NapiFeryn BioTech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersŁódź
Employee Range3
Year Founded2014
Last FundingSep 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?